Literature DB >> 12754160

A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Barbara K. Lipska1, Daniel R. Weinberger.   

Abstract

In the context of our current knowledge about schizophrenia, heuristic models of psychiatric disorders may be used to test the plausibility of theories developed on the basis of new emerging biological findings, explore mechanisms of schizophrenia-like phenomena, and develop potential new treatments. In a series of studies, we have shown that neonatal excitotoxic lesions of the rat ventral hippocampus (VH) may serve as a heuristic model. The model appears to mimic a spectrum of neurobiological and behavioral features of schizophrenia, including functional pathology in presumably critical brain regions interconnected with the hippocampal formation and targeted by antipsychotic drugs - the striatum/nucleus accumbens and the prefrontal cortex, and leads in adolescence or early adulthood to the emergence of abnormalities in a number of dopamine related behaviors. Moreover, our data show that even transient inactivation of the ventral hippocampus during a critical period of development, that produces subtle, if any, anatomical changes in the hippocampus, may be sufficient to disrupt normal maturation of the prefrontal cortex (and perhaps, other interconnected late maturing regions) and trigger behavioral changes similar to those observed in animals with the permanent excitotoxic lesion. These results represent a potential new model of aspects of schizophrenia without a gross anatomical lesion.

Entities:  

Year:  2002        PMID: 12754160     DOI: 10.1080/1029842021000022089

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  61 in total

1.  Hippocampal pathologic findings in schizophrenia. A morphometric study.

Authors:  D V Jeste; J B Lohr
Journal:  Arch Gen Psychiatry       Date:  1989-11

Review 2.  Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior.

Authors:  H Steiner; C R Gerfen
Journal:  Exp Brain Res       Date:  1998-11       Impact factor: 1.972

3.  Is schizophrenia a neurodevelopmental disorder?

Authors:  R M Murray; S W Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-19

4.  Cell loss in the hippocampus of schizophrenics.

Authors:  P Falkai; B Bogerts
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

5.  Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

Authors:  A Imperato; M C Obinu; G Carta; M S Mascia; M A Casu; G L Gessa
Journal:  Eur J Pharmacol       Date:  1996-12-19       Impact factor: 4.432

Review 6.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

7.  Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.

Authors:  Z H Meng; D L Feldpaush; K M Merchant
Journal:  Brain Res Mol Brain Res       Date:  1998-10-30

8.  The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.

Authors:  D L Feldpausch; L M Needham; M P Stone; J S Althaus; B K Yamamoto; K A Svensson; K M Merchant
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

9.  Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1994-05       Impact factor: 7.853

10.  Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.

Authors:  S L Eastwood; B McDonald; P W Burnet; J P Beckwith; R W Kerwin; P J Harrison
Journal:  Brain Res Mol Brain Res       Date:  1995-04
View more
  34 in total

Review 1.  Gene-environment interplay in schizopsychotic disorders.

Authors:  Tomas Palomo; Trevor Archer; Richard M Kostrzewa; Rrichard J Beninger
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

3.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

4.  Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.

Authors:  Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

5.  Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls.

Authors:  Stefan Ehrlich; Stefan Brauns; Anastasia Yendiki; Beng-Choon Ho; Vince Calhoun; S Charles Schulz; Randy L Gollub; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2011-03-24       Impact factor: 9.306

6.  Pain sensitivity is altered in animals after subchronic ketamine treatment.

Authors:  Axel Becker; Gisela Grecksch; Helmut Schröder
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

7.  Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.

Authors:  Jibran Y Khokhar; Travis P Todd
Journal:  Schizophr Res       Date:  2017-03-09       Impact factor: 4.939

8.  Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice.

Authors:  Weidong Li; Yu Zhou; J David Jentsch; Robert A M Brown; Xiaoli Tian; Dan Ehninger; William Hennah; Leena Peltonen; Jouko Lönnqvist; Matti O Huttunen; Jaakko Kaprio; Joshua T Trachtenberg; Alcino J Silva; Tyrone D Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

9.  Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.

Authors:  Jeffrey A Stanley; Madhuri Vemulapalli; Jeffrey Nutche; Debra M Montrose; John A Sweeney; Jay W Pettegrew; Frank P MacMaster; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2007-05-10       Impact factor: 4.939

10.  Gestational methylazoxymethanol exposure leads to NMDAR dysfunction in hippocampus during early development and lasting deficits in learning.

Authors:  Melissa A Snyder; Alicia E Adelman; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.